United Therapeutics (UTHR) Free Cash Flow (2009 - 2026)
United Therapeutics (UTHR) posted Free Cash Flow of $363.7 million for Q1 2026, down 37.02% sequentially from $577.5 million in Q4 2025, and down 5.85% YoY from $386.3 million in Q1 2025.
United Therapeutics (UTHR) Free Cash Flow (2009 - 2026) Analysis & Trends
United Therapeutics has reported Free Cash Flow for 18 years, with the latest figure at $363.7 million in Q1 2026.
- Quarterly Free Cash Flow fell 5.85% year-over-year to $363.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 27.68% YoY) and the FY2025 annual result came in at $1.4 billion, up 33.71% from the prior year.
- Free Cash Flow fell to $363.7 million in Q1 2026 per UTHR's latest filing, from $577.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $577.5 million in Q4 2025 and troughed at $38.7 million in Q2 2023.
- A 5-year average of $272.8 million and a median of $275.3 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow sank 64.82% in 2023, then soared 345.74% in 2024.
- Over 5 years, Free Cash Flow stood at $127.5 million in 2022, then soared by 31.06% to $167.1 million in 2023, then surged by 52.3% to $254.5 million in 2024, then soared by 126.92% to $577.5 million in 2025, then tumbled by 37.02% to $363.7 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $363.7 million, $577.5 million, and $280.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 137.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 205.60 Mn |
| Jun 30, 2026 | 205.60 Mn |
| Mar 31, 2026 | 363.70 Mn |
| Mar 31, 2026 | 363.70 Mn |
| Dec 31, 2025 | 577.50 Mn |
| Dec 31, 2025 | 577.50 Mn |
| Sep 30, 2025 | 280.70 Mn |
| Sep 30, 2025 | 280.70 Mn |
| Jun 30, 2025 | 200.40 Mn |
| Jun 30, 2025 | 200.40 Mn |
| Mar 31, 2025 | 386.30 Mn |
| Mar 31, 2025 | 386.30 Mn |
| Dec 31, 2024 | 254.50 Mn |
| Dec 31, 2024 | 254.50 Mn |
| Sep 30, 2024 | 300.70 Mn |
| Sep 30, 2024 | 300.70 Mn |
| Jun 30, 2024 | 172.50 Mn |
| Jun 30, 2024 | 172.50 Mn |
| Mar 31, 2024 | 352.90 Mn |
| Mar 31, 2024 | 352.90 Mn |